Shockwave Medical, part of Johnson & Johnson MedTech, is a global leader in the field of circulatory restoration. Its Intravascular Lithotripsy technology has transformed the treatment of atherosclerotic cardiovascular disease by safely using sonic pressure waves to disrupt calcified plaque. Its Reducer technology, under clinical investigation in the U.S. and CE Marked in the EU and UK, is designed to provide relief to the millions of patients worldwide suffering from refractory angina.